The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial
Abstract
OBJECTIVE: To determine whether the administration of recombinant human erythropoietin (rHuEPO) to critically ill patients in the intensive care unit (ICU) would reduce the number of red blood cell (RBC) transfusions required. DESIGN: A prospective, randomized, double-blind, placebo-controlled, multicenter trial. SETTING: ICUs at three academic tertiary care medical centers. PATIENTS: A total of 160 patients who were admitted to the ICU and met the eligibility criteria were enrolled in the study (80 into the rHuEPO group; 80 into the placebo group). INTERVENTIONS: Patients were randomized to receive either rHuEPO or placebo. The study drug (300 units/kg of rHuEPO or placebo) was administered by subcutaneous injection beginning ICU day 3 and continuing daily for a total of 5 days (until ICU day 7). The subsequent dosing schedule was every other day to achieve a hematocrit (Hct) concentration of >38%. The study drug was given for a minimum of 2 wks or until ICU discharge (for subjects with ICU lengths of stay >2 wks) up to a total of 6 wks (42 days) postrandomization. MEASUREMENTS AND MAIN RESULTS: The cumulative number of units of RBCs transfused was significantly less in the rHuEPO group than in the placebo group (p<.002, Kolmogorov-Smirnov test). The rHuEPO group was transfused with a total of 166 units of RBCs vs. 305 units of RBCs transfused in the placebo group. The final Hct concentration of the rHuEPO patients was significantly greater than the final Hct concentration of placebo patients (35.1+/-5.6 vs. 31.6+/-4.1; p<.01, respectively). A total of 45% of patients in the rHuEPO group received a blood transfusion between days 8 and 42 or died before study day 42 compared with 55% of patients in the placebo group (relative risk, 0.8; 95% confidence interval, 0.6, 1.1). There were no significant differences between the two groups either in mortality or in the frequency of adverse events. CONCLUSIONS: The administration of rHuEPO to critically ill patients is effective in raising their Hct concentrations and in reducing the total number of units of RBCs they require.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effect of Stored-Blood Transfusion on Oxygen Delivery in Patients With Sepsis
Marik, P. E. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500230106037 · Cited by 812
Corwin, H. L., Parsonnet, K. C., & Gettinger, A. (1995) · Chest · doi:10.1378/chest.108.3.767 · Cited by 358
Self-citationGROEGER, J. S., GUNTUPALLI, K. K., STROSBERG, M., HALPERN, N., RAPHAELY, R. C., CERRA, F., & KAYE, W. (1993) · Critical Care Medicine · doi:10.1097/00003246-199302000-00022 · Cited by 273
Erythropoietin response is blunted in critically ill patients
Rogiers, P., Zhang, H., Leeman, M., Nagler, J., Neels, H., Mélot, C., & Vincent, J.-L. (1997) · Intensive Care Medicine · doi:10.1007/s001340050310 · Cited by 272
Use of Recombinant Human Erythropoietin Outside the Setting of Uremia
Cazzola, M., Mercuriali, F., & Brugnara, C. (1997) · Blood · doi:10.1182/blood.v89.12.4248 · Cited by 262
Fitzgerald, R. D., Martin, C. M., Dietz, G. E., Doig, G. S., Potter, R. F., & Sibbald, W. J. (1997) · Critical Care Medicine · doi:10.1097/00003246-199705000-00004 · Cited by 230
Erythropoietin response to critical illness
Krafte‐Jacobs, B., Levetown, M., Bray, G. L., Ruttimann, U. E., & Pollack, M. M. (1994) · Critical Care Medicine · doi:10.1097/00003246-199405000-00018 · Cited by 125
Gabriel, A., Kozek, S. A., Chiari, A., Fitzgerald, R. D., Grabner, C. M., Geissler, K. H., ZIMPFER, M., Stockenhuber, F., & Bircher, N. G. (1998) · doi:10.1097/00005373-199802000-00023 · Cited by 100
The Search for Blood Substitutes
Nucci, M. L., & Abuchowski, A. (1998) · Scientific American · doi:10.1038/scientificamerican0298-72 · Cited by 40
Cited by
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Dellinger, R. P., Levy, M. M., Carlet, J. M., Bion, J., Parker, M. M., Jaeschke, R., Reinhart, K., Angus, D. C., Brun-Buisson, C., Beale, R., et al. (2008) · Intensive Care Medicine · doi:10.1007/s00134-007-0934-2 · Cited by 6,772
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Severe Sepsis and Septic Shock
Angus, D. C., & van der Poll, T. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208623 · Cited by 3,961
Metadata
- Authors
- Corwin, H. L., Gettinger, A., Rodriguez, R. M., Pearl, R. G., Gubler, K. D., Enny, C., Colton, T., & Corwin, M. J.
- Venue
- Critical Care Medicine
- Published
- 1999-11
- Volume
- 27
- Issue
- 11
- Pages
- 2346-2350
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W1970827178
- Cited by
- 351
- References
- 9
- FWCI
- 9.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial. https://app.cochat.ai/papers/10.1097/00003246-199911000-00004
- The paper
- Corwin, H. L., Gettinger, A., Rodriguez, R. M., Pearl, R. G., Gubler, K. D., Enny, C., Colton, T., & Corwin, M. J. (1999). Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial. Critical Care Medicine. https://doi.org/10.1097/00003246-199911000-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.